1-1 of 1
John H. Proffitt
Close
Sort by
Journal Articles

Alemtuzumab is an effective therapy for chronic lymphocytic leukemia with p53 mutations and deletions

Clinical Trials & Observations
Gerard Lozanski, Nyla A. Heerema, Ian W. Flinn, Lisa Smith, Jennifer Harbison, Jennifer Webb, Mollie Moran, Margaret Lucas, Thomas Lin, Marcy L. Hackbarth, John H. Proffitt, David Lucas, Michael R. Grever, John C. Byrd
Journal: Blood
Blood (2004) 103 (9): 3278–3281.
https://doi.org/10.1182/blood-2003-10-3729
Published: 2004